ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,751.07
      0.90%
      US Tech 100
      19,480.00
      1.12%
      Dow Jones
      42,352.75
      0.81%
      Brent Oil
      77.97
      0.00%
      Bitcoin
      62,077.55
      0.00%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Inhibrx Biosciences Inc (INBX) Quote

      Inhibrx Biosciences Inc

      Inhibrx Biosciences Inc (INBX)

      NASDAQ
      14.76
      -0.12
      (-0.81%)
      Closed October 04 4:00PM
      Delayed by 15 minutes
      14.76
      0.00
      (0.00%)
      After Hours: 5:12PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      14.76
      Bid
      14.20
      Ask
      16.55
      Volume
      51,267
      14.67 Day's Range 15.0109
      10.80 52 Week Range 39.79
      Market Cap
      213.664M
      Previous Close
      14.88
      Open
      14.89
      Last Trade
      102
      @
      14.76
      (priorref)
      Last Trade Time
      Financial Volume
      $ 758,760
      VWAP
      14.8002
      Average Volume (3m)
      106,853
      Shares Outstanding
      14,475,904
      Dividend Yield
      -
      PE Ratio
      -1.48
      Earnings Per Share (EPS)
      -10.71
      Revenue
      1.63M
      Net Profit
      -154.96M

      About Inhibrx Biosciences Inc

      We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.inhibrx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was $14.88. Over the last year, Inhibrx Biosciences shares have traded in a share price range of $ 10.80 to $ 39.79.

      Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is $215.40 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.48.

      Ask ADVFN Intelligence (AI)

      INBX Latest News

      More News

      Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

      Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

      August 13 2024
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 31 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form POSASR - Post-effective Amendment to an automatic shelf registration statement

      May 30 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 30 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      May 28 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.57-3.7181996086115.3316.087514.7610150715.39449787CS
      4-1.56-9.5588235294116.3217.7914.7611969015.82685691CS
      121.3810.313901345313.3817.7910.810685314.41837447CS
      26-20.34-57.948717948735.135.4210.834071227.99760439CS
      52-3.18-17.725752508417.9439.7910.846270030.191375CS
      156-17.69-54.514637904532.4547.97.6743851425.85790842CS
      260-4.94-25.07614213219.750.977.6735707825.98539019CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CHSNChanson International Holding
      $ 11.22
      (269.08%)
      		14.74M
      PEVPhoenix Motor Inc
      $ 1.0607
      (205.24%)
      		228.39M
      ENTOEntero Therapeutics Inc
      $ 0.60
      (72.20%)
      		10.42M
      BENFBeneficient
      $ 1.8914
      (58.94%)
      		108.3M
      FORDForward Industries Inc
      $ 5.3254
      (52.15%)
      		18.44M
      ADDColor Star Technology Company Ltd
      $ 0.2701
      (-39.98%)
      		14.35M
      DUOFangDD Network Group Ltd
      $ 2.53
      (-32.89%)
      		27.74M
      ICCTiCoreConnect Inc
      $ 0.4102
      (-31.50%)
      		1.65M
      ZENAZenaTech Inc
      $ 3.91
      (-29.55%)
      		212.12k
      SPAISafe Pro Group Inc
      $ 1.93
      (-25.77%)
      		238.67k
      NVDANVIDIA Corporation
      $ 124.92
      (1.68%)
      		244.44M
      PEVPhoenix Motor Inc
      $ 1.0607
      (205.24%)
      		228.39M
      SQQQProShares UltraPro Short QQQ
      $ 7.43
      (-3.63%)
      		184.42M
      NCNCnoco noco Inc
      $ 0.144
      (8.60%)
      		147.34M
      BENFBeneficient
      $ 1.8914
      (58.94%)
      		108.3M

      INBX Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      INBX under $20
      👍️0
      Monksdream Monksdream 4 weeks ago
      INBX under $15
      👍️0
      Monksdream Monksdream 6 months ago
      INBX over $30
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      heres the dolla...boom!!
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      INBX DOLLA RUMMER IN PROCESS
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      INBX...PRE MARKET VOL
      👍️0
      Jaydixson1 Jaydixson1 2 years ago
      Seems to be dropping
      👍️0
      make it happen make it happen 2 years ago
      Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

      Profitability
      Profit Margin 0.00%
      Operating Margin -1,448.76%

      Management Effectiveness
      Return on Assets -37.98%
      Return on Equity -562.25%

      Income Statement
      Revenue 7.03M
      Revenue Per Share 0.18
      Quarterly Revenue Growth (yoy) -25.50%
      Gross Profit -64.21M
      EBITDA -100.6M
      Net Income Avi to Common -110.75M
      Diluted EPS -2.44

      Balance Sheet
      Total Debt 175.7M
      Book Value Per Share -0.13

      Cash Flow Statement
      Operating Cash Flow -90.16M
      Levered Free Cash Flow -46.31M
      👍️0

      Your Recent History

      NASDAQ
      INBX
      Inhibrx Biosciences
      Delayed Upgrade Clock